CAS: 286456-42-6 - 1,2,4-Triazolo[4,3-b]pyridazine,3-(2,5-difluorophenyl)-7-(1,1-dimethylethyl)-6-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]-
Formula:C19H19F2N7O
InChI:InChI=1S/C19H19F2N7O/c1-19(2,3)13-8-15-24-25-17(12-7-11(20)5-6-14(12)21)28(15)26-18(13)29-9-16-22-10-23-27(16)4/h5-8,10H,9H2,1-4H3
InChI key:InChIKey=BQDUNOMMYOKHEP-UHFFFAOYSA-N
SMILES:FC=1C=CC(F)=C(C1)C2=NN=C3C=C(C(=NN32)OCC4=NC=NN4C)C(C)(C)C
1,2,4-Triazolo[4,3-b]pyridazine, 3-(2,5-difluorophenyl)-7-(1,1-dimethylethyl)-6-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]-
CAS:286456-42-6
Formula:
C19H19F2N7O
Color and Shape:
Solid
Molecular weight:
399.3973
Ref: IN-DA002VZ5
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
L-838417
Controlled ProductCAS:286456-42-6
Applications L-838417 is an anxiolytic agent and a selective GABAA receptor partial agonist that selectively …
Formula:
C19H19F2N7O
Color and Shape:
Neat
Molecular weight:
399.40
Ref: TR-L838417
10mg | 313.00 € | ||
50mg | 1,179.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
L 838417
CAS:286456-42-6
Selective partial GABAA receptor antagonist of subtypes α1, α2, α3, α5 subunits. Non-sedative anxiolytic effects …
Formula:
C19H19F2N7O
Purity:
Min. 95%
Color and Shape:
White/Off-White Solid
Molecular weight:
399.16191
Ref: 3D-FD24821
1mg | 168.00 € | ||
2mg | 260.00 € | ||
5mg | 457.00 € | ||
10mg | 633.00 € | ||
25mg | 1,013.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
L-838417
CAS:286456-42-6
L-838417 is a GABAA receptor subtype-selective benzodiazepine site-selective ligand and GABAA receptor-positive modulator used in …
Formula:
C19H19F2N7O
Purity:
98.12% - 99.82%
Color and Shape:
Solid
Molecular weight:
399.4
Ref: TM-T19702
1mg | 55.00 € | ||
5mg | 207.00 € | ||
10mg | 330.00 € | ||
25mg | 721.00 € | ||
50mg | 1,151.00 € | ||
100mg | 1,841.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025